Diaceutics believe that every  patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. They provide the world’s leading pharma and biotech companies with an end-to-end commercialisation solution for the launch of precision medicine, enabled by DXRX - The Diagnostic Network. They believe that DXRX is the only diagnostic commercialisation platform designed specifically for precision medicine, integrating multiple pipelines of real-world, real-time diagnostic testing data from a global network of labs. Diaceutics’ data capability is one of the three key value drivers it has integrated into its  unique DXRX platform, alongside its global lab network and product suite tailored for precision medicine.


They claim to work with leading pharma companies including Novartis, Roche/Genentech, AstraZeneca, Pfizer, BMS, Merck and Amgen.


Website: https://www.diaceutics.com


This company deals with the top 5 healthcare countries in Europe.



Topic last reviewed: 26/08/25